Soft tissue augmentation at immediate implant placement
Dr. Ignacio Sanz-Martín
Lausanne, Switzerland
Patient: 49 years, female
Clinical situation: healthy patient, smoker (< 10 cig/day), no history of periodontitis, presented root resorption in tooth 11. Tooth was scheduled for extraction.
Surgical solution: tooth extraction with immediate implant placement and simultaneous soft tissue augmentation.
Restorative solution: Nobel Procera ASC abutment with screw-retained crown
Surgery date: April 04, 2017
Total treatment time: 6 months
Tooth position: 11 (FDI)
Initial clinical solution
Frontal view (left) and occlusal view (right).
Surgical procedure
Tooth extraction – frontal view (left) and occlusal view (right).
Surgical procedure
Probing of buccal bone (left).
Placed 13 x 3.5mm NobelActive™ implant (center).
Insertion of a DBBM block (right).
Surgical procedure
Side and top view of the prepared creos™ mucogain matrix. The matrix is folded in order to increase the volume to be augmented, and cut to shape in a wet state (left).
View of creos™ mucogain over the implantation site (right).
Surgical procedure
Preparation of a buccal pouch for soft tissue volume augmentation with the «envelope technique» (left).
Insertion of creos™ mucogain in the pocket (center).
Fixation of creos™ mucogain to neighboring soft tissue to minimize movements during the healing phase (right).
Surgical procedure
Frontal view after placement of creos™ mucogain. Note that creos™ mucogain is sutured to the neighboring soft-tissue to minimize movement during the healing phase (left).
Occlusal view after placement of creos™ mucogain (right).
Outcome
Occlusal view of the soft tissue, at initial situation (top left) and after 6 months healing (bottom left).
Frontal view after 6 months, with the definitive restoration (right).
Outcome
Side and occlusal view (left).
Frontal view of the clinical outcome after 1 year (right).
-
Angulated screw channel solutionsImproved esthetics and easier access.
-
creos™ mucogainUnique oriented porous structure designed for guided soft tissue regeneration.
Share this clinical case
Sign up for our blog update
Get the latest clinical cases, industry news, product information and more.
© Nobel Biocare Services AG, 2020. All rights reserved. creos xenogain is distributed by: Nobel Biocare. Legal manufacturer: Nibec Co., Ltd. Iwol electricity-electronic Agro-industrial Complex, 116 Bamdi-gil, Iwol-myeon, Jincheon-gun, Chungcheongbuk-do, 27816 Korea. DTX Studio, Nobel Biocare, the Nobel Biocare logotype and all other trademarks are, if nothing else is stated or is evident from the context in a certain case, trademarks of Nobel Biocare. Please refer to nobelbiocare.com/trademarks for more information. Other trademarks are either registered trademarks or trademarks of their respective owners. Product images are not necessarily to scale. Disclaimer: Some products may not be regulatory cleared/released for sale in all markets. Please contact the local Nobel Biocare sales office for current product assortment and availability. For prescription use only. All product images are for illustration purposes only and may not be an exact representation of the product. Caution: Federal (United States) law or the law in your jurisdiction restricts this device to sale by or on the order of a dentist or a physician. See Instructions For Use for full prescribing information, including indications, contraindications, warnings and precautions. Nobel Biocare does not take any liability for any injury or damage to any person or property arising from the use of this clinical case. This clinical case is not intended to recommend any measures, techniques, procedures or products, or give advice, and is not a substitute for medical training or your own clinical judgement as a healthcare professional. Viewers should never disregard professional medical advice or delay seeking medical treatment because of something they have seen in this clinical case. Full procedure is not shown. Certain sequences have been cut.